Overview and Scope
Histoplasmosis
treatment refers to the medical interventions and therapies used to manage and
eliminate the fungal infection caused by the Histoplasma capsulatum fungus.
This fungus occurs in dirt, especially near areas where vast quantities of bird
or bat droppings accumulate. The specific treatment approach may vary based on
the severity of the infection, the patient's overall health and the presence of
any underlying medical conditions.
Sizing and Forecast
The histoplasmosis treatment market size has grown strongly in recent
years. It will grow from $4.74 billion in 2023 to $5.13 billion in 2024 at a
compound annual growth rate (CAGR) of 8.2%.
The growth in the historic period
can be attributed to geographic prevalence, awareness and diagnosis, global
health initiatives, research and drug development.
The histoplasmosis treatment market size is expected to see strong growth in
the next few years. It will grow to $7.04 billion in 2028 at a compound annual
growth rate (CAGR) of 8.2%. The growth
in the forecast period can be attributed to telemedicine and remote
consultations, patient education and support, reimbursement policies. Major
trends in the forecast period include antifungal resistance management,
combination therapies, immunomodulatory therapies, advanced diagnostic tools.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/histoplasmosis-treatment-global-market-report
Segmentation & Regional Insights
The histoplasmosis treatment market covered in this report is segmented –
1) By Drug Type: Amphotericin B; Itraconazole; Ketoconazole; Other Drug Type
2) By Mode of Administration: Injectable; Oral; Other Mode Of Administration
3) By Patient Type: Pediatric; Adult
4) By End-User: Hospital Pharmacies; Private Clinics; Drug Stores; Retail
Pharmacies; E-Commerce; Other End-Users
North America was the largest region in the histoplasmosis treatment market in
2023. The regions covered in histoplasmosis treatment market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the
report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12994&type=smp
Major Driver Impacting Market Growth
The rising incidence of chronic diseases is expected to propel the growth
of the histoplasmosis treatment market going forward. Chronic disease is a form
of illness that lasts three months or more and can deteriorate with time.
Histoplasmosis treatment improves respiratory health, reduces inflammation,
enhances immune system function and improves patients' quality of life
suffering from chronic diseases. For instance, in January 2023, according to
the National Library of Medicine, a US-based agency, the number of people in
the US aged 50 and older who have at least one chronic condition would increase
by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the
rising incidence of chronic diseases is driving the growth of the histoplasmosis
treatment market.
Key Industry Players
Major players in the histoplasmosis treatment market are Pfizer Inc., Johnson and Johnson Ltd., F.
Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A,
Bristol Myers Squibb, AstraZeneca PLC, Abbott laboratories, GSK PLC, Eli Lilly
and Company, Gilead Sciences, Teva Pharmaceutical Industries Ltd., Astellas
pharma US Inc., Mylan N.V., Biogen Inc., Bausch Health Companies Inc.,
Mitsubishi Tanabe Pharma Corporation, AB Science, Ionis Pharmaceuticals Inc.,
Advanz Pharma Corp., Leadiant Biosciences, IMMY, Sigma Tau Pharmaceuticals Inc.
The histoplasmosis treatment market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Generic
Pharmaceuticals Global Market Report 2024
Pharmaceutical
Drugs Global Market Report 2024
AI
In Pharma Global Market Report 2024
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment